Oncology & Cancer

Protein may protect tumor-initiating breast cancer cells

Massachusetts General Hospital investigators have identified a protein that may play an essential role in maintaining a population of tumor-initiating cells (TICs)—treatment-resistant cells responsible for cancer recurrence ...

Oncology & Cancer

Zoledronic acid every 12 weeks noninferior in bone metastases

(HealthDay)—Use of zoledronic acid every 12 weeks does not result in increased risk of skeletal events compared with use every four weeks among patients with bone metastases due to breast cancer, prostate cancer, or multiple ...

page 19 from 31